New humanised mouse model provides insight into immunotherapy resistance
Scientists at The Wistar Institute, Philadelphia, USA, have created an advanced humanised immune system mouse…
Browsing: anti-PD-1 therapy
Trial shows pembrolizumab performs better than chemotherapy in second line treatment of advanced oesophageal cancer
Announced today were the first presentation of results from KEYNOTE-181, a Phase 3 trial investigating…
Cancer patients may experience delayed skin effects of anti-PD-1 therapy
Cancer patients receiving anti-PD-1 therapies who develop lesions, eczema, psoriasis, or other forms of auto-immune…